Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference11 articles.
1. Pauling JD, Hughes M, Pope JE (2019) Raynaud’s phenomenon-an update on diagnosis, classification and management. Clin Rheumatol:1–14.
https://doi.org/10.1007/s10067-019-04745-5
2. Jacobs MJ, Breslau PJ, Slaaf DW, Reneman RS, Lemmens JA (1987) Nomenclature of Raynaud’s phenomenon: a capillary microscopic and hemorheologic study. Surgery 101(2):136-145.
http://www.ncbi.nlm.nih.gov/pubmed/3810484
. Accessed 30 Nov 2015
3. Rustin MH, Kovacs IB, Sowemimo-Coker SO, Maddison PJ, Kirby JD (1985) Differences in red cell behaviour between patients with Raynaud’s phenomenon and systemic sclerosis and patients with Raynaud’s disease. Br J Dermatol 113(3):265-272.
http://www.ncbi.nlm.nih.gov/pubmed/3877518
. Accessed 17 Aug 2016
4. Vayá A, Todolí J, Calvo J, Romagnoli M, Ricart JM (2008) Haemorheological profile in patients with systemic sclerosis. Clin Hemorheol Microcirc 40(3):243-248.
http://europepmc.org/abstract/med/19029648
. Accessed 2 Dec, 2015
5. Weber H, Schmid-Schonbein H, Lemmens H (1985) Plasmapheresis as a treatment of Raynaud’s attacks: microrheological differential diagnosis and evaluation of efficacy. Clin Hemorheol Microcirc 5:85–97